The new (April 2017) Investor presentation cleared up a lot of my questions. It was recently updated on the website. I think it was the same one they used at the Monaco presentation. Ziv is no longer mentioned and the myeloma/psoriasis past and current studies are all clearly shown.

http://www.owcpharma.com/wp-content/uploads/2...l-2017.pdf